James Emmett Young

CFO

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 1 buy · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€33k

▼ Sales (0 ops.)

—

Latest filing published 21 May 2025 for TriSalus Life Sciences, Inc., €61k. Read the official filing

Filing timeline

BuySale

James Emmett Young

Insider track record

Disclosed buys

Disclosed sells

Signal history

Closed purchases

Market purchases

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

TriSalus Life Sciences, Inc. 1 purchase · last 06 Feb 2025

Since each purchase

TriSalus Life Sciences, Inc.
Filed 06 Feb 2025 · 619 days ago · €33k
-18.9%
Entry US$5.57 · Close at T+365 US$4.52

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

James Emmett Young: trading record in brief

James Emmett Young appears in our data through filings on TriSalus Life Sciences, Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 27 January 2025 and the latest from 19 May 2025.

No open-market sale appears; the market trades are 1 purchase worth €33k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 share grants.

The latest filing, published on 21 May 2025, reports a share grant of €61k in TriSalus Life Sciences, Inc. The last insider purchase was made public on 6 February 2025, 619 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.